Study Highlights Concerns on Police Involvement in Emergency Mental Health Transfers

The police don’t have a good reputation when it comes to dealing with individuals with mental health crises. Police encounters have repeatedly proven to be particularly dangerous for people with mental illness, with these encounters often ending in injury and failing to provide the involved individuals the mental help they need. Even so, a recent study has revealed that university health centers in the Ontario region still rely on law enforcement for emergency mental-health transfers.

The study, whose findings were reported in the “Canadian Medical Association Journal,” shows that health practitioners often prefer to call the police, even though they regularly use physical restraints and their altercations often end in injury.

With suicidal behavior and self-harm rates among Canadian university students on the rise, investigators led by Juveria Zaheer, University of Toronto assistant professor of psychiatry, sought to investigate how physicians in Ontario-area universities responded to students in mental distress.

The Ontario Mental Health Act requires doctors who believe a patient presents a high risk of self-harm to fill out a Form 1 Application by Physician for Psychiatric Assessment to authorize their transfer to an ER for emergency psychiatric evaluation. Although the overall number of mandated mental health transfers for university students in the Ontario area has increased since 2014, there was little data on how these transfers were actually being facilitated. Mental health transfers are an under-researched topic, the researchers wrote in the study, stating that this was just part of a larger gap in knowledge on how people with mental health distress were transported to hospitals.

All the physicians involved in the study described how involving law enforcement in mental health transfers broke the students’ trust in them, destroyed the therapeutic relationship and incentivized the students to avoid going to the clinic in the future. One physician said that being handcuffed and walked out of the building into a waiting police car seemed “brutal and traumatic” for the patient and showed that the environment was neither caring nor supportive.

The use of law enforcement in these transfers has been controversial. One study participant reports that the police used restraints nine out of ten times, stating that the experience could be quite traumatic for patients.

While some health professionals say the use of police is integral to ensuring the patient’s safety, that sentiment isn’t widely supported. Mental health advocates argue that law enforcement and their use of physical restraints traumatizes and stigmatizes people with mental illness. Furthermore, they say that it perpetuates the notion that people with mental illness are criminals.

The very fact that the police have been persistently complicit in violence against minorities and marginalized communities underscores the need for a systematic review of their involvement in mental health transfers.

Most of the surveyed physicians relied on law enforcement because of limited resources, staff shortages and liability concerns. This reliance, the researchers concluded, contributes to a deadly cycle of stigmatization, marginalization, violence, fear and distrust for mental health patients, especially those from systematically marginalized communities.

What would be of great help is a new generation of medications for mental health illnesses? Companies such as Silo Pharma Inc. (OTCQB: SILO) are on the hunt for novel treatments that can address mental health issues in a way that offers lasting results and supports patients, hopefully decreasing emergency mental health situations.

NOTE TO INVESTORS: The latest news and updates relating to Silo Pharma Inc. (OTCQB: SILO) are available in the company’s newsroom at https://ibn.fm/SILO

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Archives

Select A Month

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050